WFAG
CVS icon

Worth Financial Advisory Group’s CVS Health CVS Stock Holding History

Worth Financial Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
+5,870
New +$524K 0.25% 94
2026
Q1 		– Sell
-6,655
Closed -$528K – 68
2025
Q4 		$528K Buy
6,655
+30
+0.5% +$2.37K 0.26% 94
2025
Q3 		$499K Sell
6,625
-115
-2% -$7.88K 0.28% 89
2025
Q2 		$465K Buy
6,740
+272
+4% +$17.8K 0.29% 88
2025
Q1 		$438K Buy
6,468
+240
+4% +$14.4K 0.28% 91
2024
Q4 		$280K Sell
6,228
-90
-1% -$5.05K 0.17% 122
2024
Q3 		$397K Sell
6,318
-5,410
-46% -$316K 0.23% 102
2024
Q2 		$693K Sell
11,728
-128
-1% -$8.01K 0.45% 54
2024
Q1 		$946K Sell
11,856
-1,522
-11% -$116K 0.66% 38
2023
Q4 		$1.06M Sell
13,378
-90
-0.7% -$6.41K 0.84% 26
2023
Q3 		$940K Sell
13,468
-483
-3% -$34.2K 0.85% 26
2023
Q2 		$964K Buy
13,951
+25
+0.2% +$1.78K 0.89% 25
2023
Q1 		$1.03M Sell
13,926
-271
-2% -$22.7K 0.99% 23
2022
Q4 		$1.32M Buy
+14,197
New +$1.37M 1.54% 14

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Worth Financial Advisory Group's CVS Position: Q2 2026 in Review

Worth Financial Advisory Group opened a new position in CVS Health (CVS) in Q2 2026: 5,870 shares worth $607K. The stake represents 0.25% of the portfolio and ranks #94 among its holdings. This is a return to the name: Worth Financial Advisory Group previously reported a position in CVS as recently as Q4 2025.

Worth Financial Advisory Group first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.32M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Worth Financial Advisory Group held 5,870 shares of CVS Health worth $607K as of Q2 2026.
  • CVS Health was a new Worth Financial Advisory Group position in Q2 2026.
  • CVS Health made up 0.25% of Worth Financial Advisory Group's portfolio in Q2 2026, its #94 holding.
  • Worth Financial Advisory Group first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Worth Financial Advisory Group's CVS Health position peaked at $1.32M in Q4 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Worth Financial Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.